As the increase in therapeutic and imaging technologies is swiftly improving survival
chances for cancer patients, pancreatic cancer (PC) still has a grim prognosis and a rising …

Pancreatic cancer remains one of the major causes of cancer-related mortality. The majority
of pancreatic cancer patients are diagnosed at the advanced stage with unresectable and …

Since the advent of nanomedicine, physicians have harnessed these approaches for the
prophylaxis, detection, and therapy of life-threatening diseases, particularly cancer …

Highlights•There are no reliable biomarkers for early detection of pancreatic cancer.•There
are limited screening methods for diagnosis of pancreatic cancer.•Nanoparticles can …

Pancreatic cancer is a devastating disease with incidence increasing at an alarming rate
and survival not improved substantially during the past three decades. Although enormous …

There is a significant unmet demand for the treatment of pancreatic cancer. Many patients do
not make it to past five years after diagnosis. The effectiveness of treatment varies greatly …

Pancreatic adenocarcinoma has the worst outcome among all cancer types, with a 5-year
survival rate as low as 10%. The lethal nature of this cancer is a result of its silent onset …

Despite improvements in our understanding of pancreatic cancer and the emerging concept
of personalized medicine for the treatment of this disease, it is still the fourth most common …

Pancreatic cancer (PC), one of the most lethal solid tumors in humans, has a five-year
survival rate of only 4%. Surgical treatment is the only accepted therapy with curative intent …

Simple Summary Pancreatic ductal adenocarcinoma (PDAC) accounts for 90% of pancreatic
cancers. It is considered one of the deadliest cancers due to its high metastatic potential and …